{"id":"https://openalex.org/W1988808248","doi":"https://doi.org/10.1002/1096-9071(200007)61:3<374::aid-jmv16>3.0.co;2-7","title":"Hepatitis B e antigen seroconversion: Effects of lamivudine alone or in combination with interferon alpha","display_name":"Hepatitis B e antigen seroconversion: Effects of lamivudine alone or in combination with interferon alpha","publication_year":2000,"publication_date":"2000-01-01","ids":{"openalex":"https://openalex.org/W1988808248","doi":"https://doi.org/10.1002/1096-9071(200007)61:3<374::aid-jmv16>3.0.co;2-7","mag":"1988808248","pmid":"https://pubmed.ncbi.nlm.nih.gov/10861649"},"language":"en","primary_location":{"id":"doi:10.1002/1096-9071(200007)61:3<374::aid-jmv16>3.0.co;2-7","doi":"https://doi.org/10.1002/1096-9071(200007)61:3<374::aid-jmv16>3.0.co;2-7","is_oa":false,"landing_page_url":"https://doi.org/10.1002/1096-9071(200007)61:3<374::aid-jmv16>3.0.co;2-7","pdf_url":null,"source":{"id":"https://openalex.org/S49828768","display_name":"Journal of Medical Virology","issn_l":"0146-6615","issn":["0146-6615","1096-9071"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medical Virology","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109955079","display_name":"Geoffrey C. Farrell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I2803024705","display_name":"Westmead Hospital","ror":"https://ror.org/04gp5yv64","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2803024705","https://openalex.org/I4405259172"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Geoffrey Farrell","raw_affiliation_strings":["Storr Liver Unit, Department of Medicine, University of Sydney at Westmead Hospital, Westmead, NSW, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Storr Liver Unit, Department of Medicine, University of Sydney at Westmead Hospital, Westmead, NSW, Australia","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I2803024705"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5109955079"],"corresponding_institution_ids":["https://openalex.org/I129604602","https://openalex.org/I2803024705"],"apc_list":{"value":4730,"currency":"USD","value_usd":4730},"apc_paid":null,"fwci":0.8911,"has_fulltext":false,"cited_by_count":25,"citation_normalized_percentile":{"value":0.65697674,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"61","issue":"3","first_page":"374","last_page":"379"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10966","display_name":"Liver physiology and pathology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatitis-b-e-antigen-seroconversion","display_name":"hepatitis B e antigen seroconversion","score":0.9390000104904175},{"id":"https://openalex.org/keywords/lamivudine","display_name":"lamivudine","score":0.9890000224113464},{"id":"https://openalex.org/keywords/interferon-alpha","display_name":"interferon-alpha","score":0.9940000176429749},{"id":"https://openalex.org/keywords/chronic-hepatitis-b","display_name":"chronic hepatitis B","score":0.9739999771118164},{"id":"https://openalex.org/keywords/nucleoside-analogue-therapy","display_name":"nucleoside analogue therapy","score":0.8489999771118164},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7749999761581421},{"id":"https://openalex.org/keywords/alanine-aminotransferase","display_name":"alanine aminotransferase","score":0.953000009059906},{"id":"https://openalex.org/keywords/liver-cirrhosis","display_name":"liver cirrhosis","score":0.7710000276565552},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.6690000295639038},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.7269999980926514}],"concepts":[{"id":"https://openalex.org/C2777869810","wikidata":"https://www.wikidata.org/wiki/Q422631","display_name":"Lamivudine","level":4,"score":0.9611780643463135},{"id":"https://openalex.org/C2777451964","wikidata":"https://www.wikidata.org/wiki/Q2141450","display_name":"Seroconversion","level":3,"score":0.8127005696296692},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7377307415008545},{"id":"https://openalex.org/C2775940106","wikidata":"https://www.wikidata.org/wiki/Q10478733","display_name":"HBeAg","level":5,"score":0.6953719854354858},{"id":"https://openalex.org/C2909179924","wikidata":"https://www.wikidata.org/wiki/Q6046488","display_name":"Alpha interferon","level":3,"score":0.5866268873214722},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5440430641174316},{"id":"https://openalex.org/C2780593183","wikidata":"https://www.wikidata.org/wiki/Q6844","display_name":"Hepatitis B virus","level":3,"score":0.5123130083084106},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5040696859359741},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.500593900680542},{"id":"https://openalex.org/C2777382497","wikidata":"https://www.wikidata.org/wiki/Q6853","display_name":"Hepatitis B","level":2,"score":0.49825406074523926},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4511597752571106},{"id":"https://openalex.org/C2781228144","wikidata":"https://www.wikidata.org/wiki/Q6046441","display_name":"Interferon alfa","level":4,"score":0.4479069113731384},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.43833106756210327},{"id":"https://openalex.org/C2777333352","wikidata":"https://www.wikidata.org/wiki/Q2689559","display_name":"Nucleoside analogue","level":3,"score":0.41722720861434937},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.3177832365036011},{"id":"https://openalex.org/C2777410769","wikidata":"https://www.wikidata.org/wiki/Q2282887","display_name":"HBsAg","level":4,"score":0.2093435525894165},{"id":"https://openalex.org/C2776543447","wikidata":"https://www.wikidata.org/wiki/Q28734","display_name":"Nucleoside","level":2,"score":0.13015124201774597},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.10383805632591248},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006510","descriptor_name":"Hepatitis B Antibodies","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006513","descriptor_name":"Hepatitis B e Antigens","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D006513","descriptor_name":"Hepatitis B e Antigens","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019259","descriptor_name":"Lamivudine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019694","descriptor_name":"Hepatitis B, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019694","descriptor_name":"Hepatitis B, Chronic","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/1096-9071(200007)61:3<374::aid-jmv16>3.0.co;2-7","doi":"https://doi.org/10.1002/1096-9071(200007)61:3<374::aid-jmv16>3.0.co;2-7","is_oa":false,"landing_page_url":"https://doi.org/10.1002/1096-9071(200007)61:3<374::aid-jmv16>3.0.co;2-7","pdf_url":null,"source":{"id":"https://openalex.org/S49828768","display_name":"Journal of Medical Virology","issn_l":"0146-6615","issn":["0146-6615","1096-9071"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medical Virology","raw_type":"journal-article"},{"id":"pmid:10861649","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10861649","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medical virology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W1917187937","https://openalex.org/W1938255755","https://openalex.org/W1966202542","https://openalex.org/W1969872269","https://openalex.org/W1970493256","https://openalex.org/W1978724373","https://openalex.org/W1980912700","https://openalex.org/W2011862847","https://openalex.org/W2038358235","https://openalex.org/W2040448281","https://openalex.org/W2051070783","https://openalex.org/W2055270948","https://openalex.org/W2055293911","https://openalex.org/W2069030584","https://openalex.org/W2070906576","https://openalex.org/W2074433769","https://openalex.org/W2078035139","https://openalex.org/W2082256923","https://openalex.org/W2085990351","https://openalex.org/W2094688436","https://openalex.org/W2095273553","https://openalex.org/W2100573496","https://openalex.org/W2125105983","https://openalex.org/W2127594819","https://openalex.org/W2128721549","https://openalex.org/W2146003334","https://openalex.org/W2149836081","https://openalex.org/W2160296014","https://openalex.org/W2170268409","https://openalex.org/W2293495463","https://openalex.org/W2318639814","https://openalex.org/W2319441763","https://openalex.org/W2323719395","https://openalex.org/W2338794667","https://openalex.org/W2599064878","https://openalex.org/W2616817196","https://openalex.org/W2753977396"],"related_works":["https://openalex.org/W2149836081","https://openalex.org/W2378432238","https://openalex.org/W2401212639","https://openalex.org/W2088178095","https://openalex.org/W2377009965","https://openalex.org/W2112145547","https://openalex.org/W2350018785","https://openalex.org/W2137544368","https://openalex.org/W1015959761","https://openalex.org/W2324789096"],"abstract_inverted_index":{"Seroconversion":[0,83],"of":[1,13,46,72,78,100,110,129,188,217,250],"hepatitis":[2,15,40],"B":[3,16,41],"e":[4],"antigen":[5],"(HBeAg)":[6],"is":[7,32,93,178,209,225,241,275],"an":[8],"important":[9],"marker":[10],"for":[11,21,38,61,182,228,246],"resolution":[12],"active":[14,233],"virus":[17],"(HBV)":[18],"infection":[19],"and":[20,49,92,115,163,180,236,263],"a":[22,29,69,75,185,214,247],"long-term":[23],"positive":[24],"response":[25,144],"to":[26,65,89,106,153,169],"treatment.":[27],"Lamivudine,":[28],"nucleoside":[30],"analogue,":[31],"the":[33,107],"first":[34],"effective":[35,179],"oral":[36],"treatment":[37,58,270],"chronic":[39],"in":[42,68,96,118,147,184,201,230],"patients":[43,73,120,136,191,231],"with":[44,59,121,137,161,174,213,222,232,254],"evidence":[45],"viral":[47],"replication":[48],"liver":[50,218,234,256],"disease.":[51],"When":[52],"appropriate":[53,181],"patient":[54],"groups":[55],"are":[56,104,272],"compared,":[57],"lamivudine":[60,164,175,208,240],"1":[62],"year":[63],"leads":[64],"HBeAg":[66],"seroconversion":[67,206],"similar":[70],"proportion":[71,187],"as":[74,220],"standard":[76],"course":[77],"interferon":[79],"(IFN)":[80],"alpha":[81],"therapy.":[82],"increases":[84],"during":[85],"prolonged":[86],"therapy":[87],"(up":[88],"3":[90,156],"years),":[91],"sustained":[94],"post-treatment":[95],"more":[97,226,242],"than":[98,192,244,279],"three-quarters":[99],"patients.":[101],"Response":[102],"rates":[103],"related":[105],"pretreatment":[108,138],"level":[109],"serum":[111,122],"alanine":[112],"aminotransferase":[113],"(ALT)":[114],"reach":[116],"65%":[117,154],"those":[119,196,253,264],"ALT":[123,139],">":[124,140],"5":[125],"x":[126,142],"upper":[127],"limit":[128],"normal":[130],"(ULN)":[131],"after":[132,149,155,207],"one":[133,150],"year.":[134],"For":[135],"2":[141],"ULN,":[143],"was":[145],"seen":[146,221],"38%":[148],"year,":[151],"rising":[152],"years.":[157],"To":[158],"date,":[159],"combination":[160],"IFN":[162,193,245,269],"has":[165],"not":[166,210],"been":[167],"shown":[168],"confer":[170],"additional":[171],"benefit":[172],"compared":[173],"monotherapy.":[176],"Lamivudine":[177,274],"use":[183,229],"greater":[186],"HBV":[189,262],"infected":[190,197],"alpha,":[194],"particularly":[195],"at":[198],"birth":[199],"or":[200,271],"early":[202],"childhood.":[203],"Furthermore,":[204],"because":[205],"normally":[211],"associated":[212],"severe":[215,255],"flare":[216],"disease,":[219,257],"IFN,":[223],"it":[224],"suitable":[227,243],"disease":[235],"cirrhosis.":[237],"In":[238],"conclusion,":[239],"broad":[248],"range":[249],"patients,":[251],"including":[252],"recurrent":[258],"flares,":[259],"pre-core":[260],"mutant":[261],"who":[265],"have":[266],"failed":[267],"previously":[268],"immunosuppressed.":[273],"also":[276],"better":[277],"tolerated":[278],"IFN.":[280]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}